BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23115862)

  • 1. Truvada for HIV prophylaxis in heterosexual patients.
    DeDea L
    JAAPA; 2012 Oct; 25(10):14. PubMed ID: 23115862
    [No Abstract]   [Full Text] [Related]  

  • 2. Uptake of PrEP for HIV slow among MSM.
    Kirby T; Thornber-Dunwell M
    Lancet; 2014 Feb; 383(9915):399-400. PubMed ID: 24494225
    [No Abstract]   [Full Text] [Related]  

  • 3. The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK.
    McCormack S; Fidler S; Fisher M; ;
    Int J STD AIDS; 2012 Jan; 23(1):1-4. PubMed ID: 22362679
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential HIV prophylaxis enters Canadian pilot trial.
    Lawson J
    CMAJ; 2014 May; 186(8):E234. PubMed ID: 24710911
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.
    Radzio J; Aung W; Holder A; Martin A; Sweeney E; Mitchell J; Bachman S; Pau CP; Heneine W; García-Lerma JG
    PLoS One; 2012; 7(12):e50632. PubMed ID: 23226529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to Sachdev et al.
    Karris MY; Beekmann SE; Mehta SR; Polgreen PM
    Clin Infect Dis; 2014 Jun; 58(12):1788. PubMed ID: 24729555
    [No Abstract]   [Full Text] [Related]  

  • 7. Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
    Coutinho B; Prasad R
    Am Fam Physician; 2013 Oct; 88(8):535-40. PubMed ID: 24364575
    [No Abstract]   [Full Text] [Related]  

  • 8. Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs.
    Sachdev DD; Stojanovski K; Liu AY; Buchbinder SP; Macalino GE
    Clin Infect Dis; 2014 Jun; 58(12):1786-7. PubMed ID: 24729556
    [No Abstract]   [Full Text] [Related]  

  • 9. Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.
    Blackwell CW
    Nurse Pract; 2014 Sep; 39(9):50-3. PubMed ID: 25140852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PrEP approved in the USA: facts and discussion - permanent chemoprophylaxis for healthy people].
    Marcus U
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():42-4. PubMed ID: 23961656
    [No Abstract]   [Full Text] [Related]  

  • 11. The medicalization of HIV prevention: new opportunities beset by old challenges.
    Bayer R
    Milbank Q; 2014 Sep; 92(3):434-7. PubMed ID: 25199892
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV study yields unexpected preliminary efficacy results.
    Traynor K
    Am J Health Syst Pharm; 2008 Apr; 65(8):686-8. PubMed ID: 18387889
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA paves the way for pre-exposure HIV prophylaxis.
    Holmes D
    Lancet; 2012 Jul; 380(9839):325. PubMed ID: 22852138
    [No Abstract]   [Full Text] [Related]  

  • 14. Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?
    De Clercq E
    Med Res Rev; 2012 Jul; 32(4):765-85. PubMed ID: 22581627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emtricitabine/tenofovir disoproxil fumarate.
    Dando TM; Wagstaff AJ
    Drugs; 2004; 64(18):2075-82; discussion 2083-4. PubMed ID: 15341498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for HIV, AIDS.
    FDA Consum; 2004; 38(6):4. PubMed ID: 15675011
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada) in virologically suppressed HIV-infected patients on HAART.
    Palacios R; Hidalgo C; Ríos MJ; Rivero A; Muñoz L; Lozano F; Gutiérrez-Ravé V; Gálvez MC; del Arco A; Santos J
    Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):399-402. PubMed ID: 18841401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preexposure prophylaxis for HIV infection.
    Steinbrook R
    JAMA; 2012 Sep; 308(9):865-6. PubMed ID: 22820712
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical challenges of preexposure prophylaxis for HIV.
    Jay JS; Gostin LO
    JAMA; 2012 Sep; 308(9):867-8. PubMed ID: 22847147
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies.
    Burns DN; Grossman C; Turpin J; Elharrar V; Veronese F
    Curr HIV/AIDS Rep; 2014 Dec; 11(4):393-403. PubMed ID: 25283184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.